Skip to main content

and
  1. Article

    Open Access

    PD-L1 inhibitor versus PD-1 inhibitor plus bevacizumab with transvascular intervention in unresectable hepatocellular carcinoma

    Both atezolizumab (a PD-L1 inhibitor) plus bevacizumab (A+B) and sintilimab (a PD-1 inhibitor) plus bevacizumab (S+B) are recommended as the first-line regimen for advanced hepatocellular carcinoma (HCC) in Ch...

    Zhenkun Huang, Tiejun Chen, Wenbin Li, Jiliang Qiu in Clinical and Experimental Medicine (2024)

  2. Article

    Open Access

    Oral arsenic plus imatinib versus imatinib solely for newly diagnosed chronic myeloid leukemia: a randomized phase 3 trial with 5-year outcomes

    The synergistic effects of combining arsenic compounds with imatinib against chronic myeloid leukemia (CML) have been established using in vitro data. We conducted a clinical trial to compare the efficacy of t...

    Jie Tian, Yong-** Song, Gao-Chong Zhang in Journal of Cancer Research and Clinical On… (2024)

  3. Article

    Open Access

    Anti-metabolic agent pegaspargase plus PD-1 antibody sintilimab for first-line treatment in advanced natural killer T cell lymphoma

    Natural killer T cell lymphoma (NKTCL) is highly aggressive, with advanced stage patients poorly responding to intensive chemotherapy. To explore effective and safe treatment for newly diagnosed advanced stage...

    Jie **ong, Shu Cheng, **ao Gao, Shan-He Yu in Signal Transduction and Targeted Therapy (2024)

  4. Article

    Open Access

    Inhibition of USP1 reverses the chemotherapy resistance through destabilization of MAX in the relapsed/refractory B-cell lymphoma

    The patients with relapsed and refractory diffuse large B-cell lymphoma (DLBCL) have poor prognosis, and a novel and effective therapeutic strategy for these patients is urgently needed. Although ubiquitin-spe...

    **-Ya Li, Ji-Chuan Wu, ** Liu, Zi-Juan Li, Yong Wang, Bing-Yi Chen in Leukemia (2023)

  5. No Access

    Article

    Adjuvant chemotherapy following combined induction chemotherapy and concurrent chemoradiotherapy improves survival in N2–3-positive nasopharyngeal carcinoma patients

    This study aimed to explore the clinical value of adjuvant chemotherapy (ACT) following concurrent chemo-radiotherapy (CCRT) and induction chemotherapy (ICT) in loco-regionally advanced nasopharyngeal carcinom...

    Hao-Yun Tao, Hui Liu, Fang He, Cai-**an He in Journal of Cancer Research and Clinical On… (2022)

  6. Article

    Open Access

    ALOX15-launched PUFA-phospholipids peroxidation increases the susceptibility of ferroptosis in ischemia-induced myocardial damage

    Myocardial ischemia/reperfusion (I/R) injury is a classic type of cardiovascular disease characterized by injury to cardiomyocytes leading to various forms of cell death. It is believed that irreversible myoca...

    **ao-Hui Ma, Jiang-Han-Zi Liu, Chun-Yu Liu in Signal Transduction and Targeted Therapy (2022)

  7. Article

    Open Access

    Active demethylation upregulates CD147 expression promoting non-small cell lung cancer invasion and metastasis

    Non-small cell lung cancer (NSCLC) is a fatal disease, and its metastatic process is poorly understood. Although aberrant methylation is involved in tumor progression, the mechanisms underlying dynamic DNA met...

    Cheng-Gong Liao, **ao-Hua Liang, Yuan Ke, Li Yao, Man Liu, Ze-Kun Liu, Lin He in Oncogene (2022)

  8. Article

    Open Access

    Role of TGFβ3-Smads-Sp1 axis in DcR3-mediated immune escape of hepatocellular carcinoma

    Hepatocellular carcinoma (HCC) is a leading cause of tumour-associated mortality worldwide, but no significant improvement in treating HCC has been reported with currently available systemic therapies. Immunot...

    Hui-fang Zhu, Yan-** Liu, Ding-li Liu, Yi-dan Ma, Zhi-yan Hu in Oncogenesis (2019)

  9. No Access

    Article

    Low dose of homoharringtonine and cytarabine combined with granulocyte colony-stimulating factor priming on the outcome of relapsed or refractory acute myeloid leukemia

    To explore the effect of low dose of homoharringtonine (HHT) and cytarabine (Ara-c) combined with granulocyte colony-stimulating factor (G-CSF) priming (HAG regimen) on relapsed or refractory acute myeloid leu...

    Liu-Fang Gu, Wang-Gang Zhang, Fang-**a Wang in Journal of Cancer Research and Clinical On… (2011)